EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Simplicillium sinense sp. nov., a novel potential pathogen of tinea faciei

Qiu-Hong Yan, Qing-Rong Ni, Wei-Jie Gu, Hong-Wei Liu, Xiao-Ying Yuan, Jing-Zu Sun

Frontiers in Microbiology · 12.05.2023 · 14

DOI: 10.3389/fmicb.2023.1156027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 12.05.2023. Verfasst von Qiu-Hong Yan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Medical Mycology Center, Department of Dermatology, Air Force Medical Center, Fourth Military Medical University, Beijing, China. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Simplicillium species are widely distributed with a broad spectrum of hosts and substrates. Generally, these species are entomopathogenic or mycoparasitic. Notably, some isolates of Simplicillium lanosoniveum and Simplicillium obclavatum were obtained from human tissues. In this study, two fungi were isolated from the annular itchy patch of infected skin of a 46-year-old man with diabetes mellitus. Based on a combination of morphological characteristics and phylogenetic analysis, a novel species, Simplicillium sinense , was introduced herein. It morphologically differs from the remaining Simplicillium in the size of phialides and conidia. Additionally, it grows slowly on YPD at 37°C. Antimicrobial susceptibility testing presented that this fungus is resistant to most azole antifungals. Therefore, the diagnosis of tinea faciei was made, and after 2 weeks of being treated with oral terbinafine (250 mg, once a day) and topical terbinafine cream for 1 month, the rash was mainly resolved and no recurrence happened after 6 months of follow-up. Herein, Simplicillium sinense was introduced as a new fungal taxon. Meanwhile, a case of superficial infection caused by S. sinense was reported. So far, it is the third Simplicillium species obtained from human tissue. Meanwhile, terbinafine is recommended as the first-line antifungal treatment against Simplicillium infection.

Schlagwörter

Stichwörter der Autor:innen

Simplicillium sinenseantifungal susceptibilitypathogenphylogenetic analysestinea faciei

Autor:innen und Institutionen

  • Medical Mycology Center, Department of Dermatology, Air Force Medical Center, Fourth Military Medical University, Beijing, China.
  • State Key Laboratory of Mycology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
  • Savaid Medical School, University of Chinese Academy of Sciences, Beijing, China.

Förderung

  • National Key Research and Development Program of China

Zitieren

APA

Yan, Q. H., Ni, Q. R., Gu, W. J., Liu, H. W., Yuan, X. Y., & Sun, J. Z. (2023). Simplicillium sinense sp. nov., a novel potential pathogen of tinea faciei. Frontiers in Microbiology, 14. https://doi.org/10.3389/fmicb.2023.1156027

Vancouver

Yan QH, Ni QR, Gu WJ, Liu HW, Yuan XY, Sun JZ. Simplicillium sinense sp. nov., a novel potential pathogen of tinea faciei. Frontiers in Microbiology. 2023;14. doi:10.3389/fmicb.2023.1156027

BibTeX
@article{Yan2023,
  author = {Yan, Qiu-Hong and Ni, Qing-Rong and Gu, Wei-Jie and Liu, Hong-Wei and Yuan, Xiao-Ying and Sun, Jing-Zu},
  title = {Simplicillium sinense sp. nov., a novel potential pathogen of tinea faciei},
  journal = {Frontiers in Microbiology},
  year = {2023},
  volume = {14},
  doi = {10.3389/fmicb.2023.1156027}
}
Kostenlos starten →